1.
Pietrzykowska J, Billewicz M, Lis L, PopioĊ‚ek A, Marczyk A, Turek A, et al. Significance of zoledronic acid in the adjuvant therapy in patients with breast cancer. Pol J Public Health [Internet]. 2024 Jul. 31 [cited 2025 Jul. 7];134:37-41. Available from: https://czasopisma.umlub.pl/pjph/article/view/1211